Latest in Research & Development

Biohm Technologies expands R&D footprint with new microbiome lab in Atlanta

The company has opened a state-of-the-art research lab at Portal Innovations’ Science Square campus in Atlanta, strengthening its microbiome R&D capabilities

Find out more

EazeBio and UC Santa Cruz partner to launch instrument-free diagnostic platform for global health

The pair will co-develop a lab-independent cortisol biosensor, delivering rapid, affordable and AI-guided diagnostics for stress, metabolic health and a range of global health...
See more

Certain medicines accelerate elimination of PFAS from the body, Gothenburg study shows

Researchers at the University of Gothenburg have found that two cholesterol-lowering drugs, cholestyramine and colesevelam, can significantly speed up the removal of harmful PFAS chemicals from the body

Bioengineered bone marrow model successfully used in cancer research

Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model in vital leukaemia research

Novo Nordisk's Wegovy results in patients hitting key BMI and waist size targets

New STEP UP trial data show that semaglutide enables people with obesity to achieve BMI and waist-to-height ratio targets linked to lower cardiovascular risk, alongside significant weight loss

Veloxity Labs acquires SCIEX mass spectrometer, the ZenoTOF 8600 System, to accelerate peptide and complex bioanalysis

Veloxity Labs, a bioanalytical CRO built for programmes that need speed with purpose, has announced the acquisition of the ZenoTOF 8600 system from SCIEX, a global leader in life science analytical technologies
You need to be a subscriber to read this article.
Click here to find out more.

Solving the rare disease puzzle

Dan Williams, founder at SynaptixBio, explores the complex challenges of diagnosing and treating rare diseases, their impact on patients and healthcare systems and how small biotech firms are reshaping therapeutic innovation

Lilly partners with NVIDIA to build pharma’s most powerful AI supercomputer for faster drug discovery

Eli Lilly has joined forces with NVIDIA to create the world’s most powerful pharmaceutical supercomputer, designed to accelerate AI-driven medicine discovery and manufacturing — all while running entirely on renewable energy

Jabil and Kymanox collaboration to deliver end-to-end development, regulatory and manufacturing solutions

Jabil and Kymanox are partnering to combine their regulatory, technical, and manufacturing expertise to help life science companies streamline development and bring complex therapies to market faster

Aseptic spray drying: Transforming biotherapeutics for a new era

With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

Latest posts in Research & Development

Piramal Pharma Solutions formalises partnership with IntoCell

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the field

Immunology CRO reports shift to autoimmunity projects

RoukenBio reports a sharp rise in autoimmunity drug development projects and an almost 50% decrease in immuno-oncology (I-O) studies, showcasing the shift in drug development trends

Merck partners with Promega to advance 3D cell drug discovery technologies

Partnership combines Merck’s chemistry and organoid expertise with Promega’s assay technologies

Certified biobased resins bring sustainable lab filtration to Cytiva’s customers

Certified materials enable labs to choose more sustainable options without changing workflows or compromising performance

Syngene International plans to add bioconjugation suite for end-to-end antibody-drug conjugates development

Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services

Cellarity unveils AI-driven framework for cell state-correcting drug discovery in the journal Science

Biotech innovator Cellarity publishes a breakthrough blueprint integrating multiomics and machine learning to accelerate discovery of complex disease therapies, alongside the release of three open-access single-cell datasets

Orion secures exclusive license to Abzena’s CHAb-designed oncology antibody

The deal strengthens Orion’s cancer R&D pipeline with a de-risked monoclonal antibody developed using Abzena’s proprietary Composite Human Antibody (CHAb) and AbZelectPRO platforms

GemPharmatech and MSK to enter antibody research collaboration

The Memorial Sloan Kettering Cancer Center (MSK) will use GemPharmatech's antibody discovery platform to accelerate the development of next-generation cancer therapies

Immusoft receives FDA Fast Track Designation for ISP-001, a first-in-class engineered B cell therapy for MPS I

Immusoft’s ISP-001, designed to deliver continuous enzyme production through engineered B cells, becomes the first clinical-stage therapy of its kind to receive FDA Fast Track designation

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled

Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours

The pair will co-develop two investigational ADC assets directed against targets expressed in a broad range of cancers, adding a new class of bispecific and dual-payload ADC therapeutics to Samsung Bioepis' oncology portfolio

Sponsor content

Guardtech supporting malaria fight in East Africa with portable 11-bay lab

Suffolk-based experts provide Cleancube Multi 11 for Oxitec’s Friendly mosquito programme in Djibouti

Optimising sample traceability with laser marking technology

Speed and precision in high-throughput tube identification

Flowchem teaching manual now available to download

Guide offers step-by-step instructions for ten reactions including Nobel Prize-winning examples

Cut Argon use and costs with Shimadzu’s ICPMS-2040/2050

New Mini-Torch System offers precision analysis with 40% less Argon

Driving ADC innovation with complex chemistry solutions

Abzena’s tailored chemistry expertise enables scalable, high-quality bioconjugate development from discovery to GMP production

ProImmune Ltd introduces ProVE SL Self-Loading MHC Class I Monomers to improve T cell research flexibility

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel...

Streamlining bioconjugation for next-generation ADC development

Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates

TurboFil offers industry-leading glove testing systems

Partnership with RAVONA delivers precision and compliance in aseptic environments

How to optimise your quality culture and maturity for success

NSF outlines how aligning culture, leadership and systems can strengthen compliance and performance

Shimadzu launches ALTRACE energy dispersive X-ray fluorescence spectrometer

High-sensitivity analysis and automated measurements for food, environmental, and pharmaceutical inspections

Accelerating self-administration and homecare with large-volume prefillable glass syringe

SCHOTT Pharma launches 5.5 ml syringe compatible with autoinjectors to enable comfortable home injections

Aenova expands sterile fill & finish manufacturing at its Latina site

New line to boost biologics capacity and support a wide range of container formats

Featured companies

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life... Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or... Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable.
See more